GWSG
TXG icon

GPS Wealth Strategies Group’s 10x Genomics TXG Stock Holding History

GPS Wealth Strategies Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-50
Closed -$585 – 1498
2025
Q3 		$585 Hold
50
– – ﹤0.01% 1508
2025
Q2 		$579 Hold
50
– – ﹤0.01% 1470
2025
Q1 		$437 Hold
50
– – ﹤0.01% 1405
2024
Q4 		$718 Buy
+50
New +$789 ﹤0.01% 1313
2024
Q1 		– Sell
-3
Closed -$168 – 1303
2023
Q4 		$168 Hold
3
– – ﹤0.01% 1217
2023
Q3 		$124 Buy
+3
New +$156 ﹤0.01% 1256

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GPS Wealth Strategies Group's TXG Position: Q4 2025 in Review

GPS Wealth Strategies Group sold out of 10x Genomics (TXG) in Q4 2025, closing a stake of 50 shares — an estimated $585 sold.

GPS Wealth Strategies Group first reported a position in TXG in Q3 2023 and held it in 6 quarters. The position peaked at $718 in Q4 2024. 322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

  • GPS Wealth Strategies Group reported no remaining 10x Genomics position as of Q4 2025 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 50 10x Genomics shares in Q4 2025, an estimated $585.
  • GPS Wealth Strategies Group first reported a position in 10x Genomics in Q3 2023 and held it in 6 quarters.
  • GPS Wealth Strategies Group's 10x Genomics position peaked at $718 in Q4 2024.
  • 322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.